DJIA 16,880.36 -31.75 -0.19%
NASDAQ 4,462.90 20.20 0.45%
S&P 500 1,970.07 0.12 0.01%
market minute promo

United Therapeutics Corp (NASDAQ: UTHR)



company name or ticker
Company Photos
(Click to zoom)

OncoGenex Pharmaceuticals (OGXI) Jumps: Stock Up 6.1% - Tale of the Tape

Manufacturing Approval for Pluristem Facility - Analyst Blog

Revenue Growth + Sane Valuation: Making A List

United Therapeutics Larger Than S&P 500 Component Owens-Illinois

United Therapeutics Corporation (UTHR): New Analyst Report from Zacks Equity Research - Zacks Equity

United Therapeutics Corporation (UTHR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Pluristem to Release Trial Results - Analyst Blog

Pluristem to Release Trial Results - Analyst Blog

Chelsea's Northera Gets Another Chance

A January advisory panel meeting and potential FDA approval in February could move the needle for this small biotech.

Pluristem Touches 52-Week High - Analyst Blog

Pluristem Touches 52-Week High - Analyst Blog

Analyst Favorites With Strong Buyback Activity: United Therapeutics Ranks As A Top Pick

Insider Trading Alert - SPLK, UTHR, IBKR, CMLS And SPG Traded By Insiders

See More Articles...